News focused on: Lab Lord S; Sandra Lord, MD; Type 1 Diabetes TrialNet; Type 1 Diabetes (T1D); Biorep Type 1 Diabetes
Press Release
Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award
Read More
Press Release
Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases
Read More
External News
Monitoring T cells may allow prevention of type 1 diabetes
Read More ➡
External News
Science in Seattle: IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function
Read the Publication ➡
News
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
Read More
Press Release
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
Read More
External News
Exploring autoimmunity's regulatory roots
Read more ➡
External News
Autoimmunity in Down Syndrome Arises From Rapid Immune Aging
Read more ➡
External News
Do you need a Covid-19 booster shot? Seattle researchers aim to find out.
Read more ➡
External News
Gene-edited T cells to treat diabetes inch closer to clinical trials
Read more ➡
External News
Hybrid Insulin Peptides are Recognized by Human T Cells in the Context of DRB1*04:01
Read more ➡
External News
Healing the Immune System: Autoimmune Breakthroughs Offer New Hope
Learn more ➡
External News
Biological 'atlas' shows dual personality for immune cells that cause type 1 diabetes
Read more ➡
External News
Screening Kids for Type 1 Diabetes in Primary Care Is Feasible
Read more ➡
News
